Your search returned 3 results.

Results
	1.	EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. [electronic resource] by Glynne-Jones, Rob Meadows, Helen Wan, Susan Gollins, Simon Leslie, Martin Levine, Ed McDonald, Alec C Myint, Sun Samuel, Les Sebag-Montefiore, David Producer: 20081006 In: International journal of radiation oncology, biology, physics vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). [electronic resource] by Middleton, Gary Brown, Sarah Lowe, Catherine Maughan, Timothy Gwyther, Stephen Oliver, Alfred Richman, Susan Blake, Denise Napp, Vicky Marshall, Helen Wadsley, Jonathan Maisey, Nick Chau, Ian Hill, Mark Gollins, Simon Myint, Sun Slater, Sarah Wagstaff, John Bridgewater, John Seymour, Matthew Producer: 20131202 In: European journal of cancer (Oxford, England : 1990) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. [electronic resource] by Tweedle, Elizabeth M Khattak, Ilyas Ang, Chin Wee Nedjadi, Taoufik Jenkins, Rosalind Park, B Kevin Kalirai, Helen Dodson, Andy Azadeh, Bahram Terlizzo, Monica Grabsch, Heike Mueller, Wolfram Myint, Sun Clark, Peter Wong, Helen Greenhalf, William Neoptolemos, John P Rooney, Paul S Costello, Eithne Producer: 20101104 In: Gut vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)